Literature DB >> 19373025

Microbicide acceptability research: recent findings and evolution across phases of product development.

Astou Coly1, Pamina M Gorbach.   

Abstract

PURPOSE OF REVIEW: Research on the acceptability of microbicides has the potential to inform the microbicide development process by shedding light on desirable product characteristics, issues around product use and potential barriers. The purpose of this review is both to synthesize recent findings that are related to microbicide acceptability, highlight areas of deficiencies, and to point to the new directions in which research is needed. RECENT
FINDINGS: Recent studies have assessed acceptability using candidate microbicides in clinical trials, surrogate products, and descriptions of hypothetical products. While most studies have focused on physical characteristics of products, some small studies have investigated participants' short-term experiences with products during sexual intercourse. Overall, as currently measured and in their present formulations, vaginal microbicides have been found to be acceptable to adolescent girls, women, heterosexual men, whereas rectal microbicides were acceptable to men who have sex with men. Few studies have examined acceptability among high-risk HIV-uninfected women. The relationship between acceptability and adherence in trials, and ultimately in real-world settings, remains unknown.
SUMMARY: Data are needed on acceptability of microbicides from larger populations, high-risk HIV-uninfected women, as well as long-term acceptability and contextual factors surrounding acceptability. The association between acceptability and long-term adherence in clinical trials or ultimately in the open market has yet to be demonstrated.

Entities:  

Year:  2008        PMID: 19373025     DOI: 10.1097/COH.0b013e32830aba00

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  15 in total

1.  Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit?

Authors:  Barbara S Mensch; Elizabeth R Brown; Karen Liu; Jeanne Marrazzo; Zvavahera Mike Chirenje; Kailazarid Gomez; Jeanna Piper; Karen Patterson; Ariane van der Straten
Journal:  AIDS Behav       Date:  2016-11

2.  Attitudes towards microbicide use for bacterial vaginosis in pregnancy.

Authors:  Marina Catallozzi; Camille Y Williams; Gregory D Zimet; Katharine M Hargreaves; Shari E Gelber; Adam J Ratner; Lawrence R Stanberry; Susan L Rosenthal
Journal:  Sex Health       Date:  2014-09       Impact factor: 2.706

3.  The future role of rectal and vaginal microbicides to prevent HIV infection in heterosexual populations: implications for product development and prevention.

Authors:  Marie-Claude Boily; Dobromir Dimitrov; Salim S Abdool Karim; Benoît Mâsse
Journal:  Sex Transm Infect       Date:  2011-12       Impact factor: 3.519

4.  "Tell Juliana": acceptability of the candidate microbicide VivaGel® and two placebo gels among ethnically diverse, sexually active young women participating in a phase 1 microbicide study.

Authors:  Alex Carballo-Diéguez; Rebecca Giguere; Curtis Dolezal; Beatrice A Chen; Jessica Kahn; Greg Zimet; Marina Mabragaña; Cheng-Shiun Leu; Ian McGowan
Journal:  AIDS Behav       Date:  2012-10

Review 5.  Clinical evaluation of microbicide formulations.

Authors:  Kathleen M Morrow; Craig Hendrix
Journal:  Antiviral Res       Date:  2010-12       Impact factor: 5.970

Review 6.  Acceptability in microbicide and PrEP trials: current status and a reconceptualization.

Authors:  Barbara S Mensch; Ariane van der Straten; Lauren L Katzen
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

7.  Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women.

Authors:  Alexandra M Minnis; Sharavi Gandham; Barbra A Richardson; Vijayanand Guddera; Beatrice A Chen; Robert Salata; Clemensia Nakabiito; Craig Hoesley; Jessica Justman; Lydia Soto-Torres; Karen Patterson; Kailazarid Gomez; Craig W Hendrix
Journal:  AIDS Behav       Date:  2013-02

Review 8.  Pre-exposure prophylaxis state of the science: empirical analogies for research and implementation.

Authors:  Sarit A Golub; Don Operario; Pamina M Gorbach
Journal:  Curr HIV/AIDS Rep       Date:  2010-11       Impact factor: 5.071

9.  Lessons for Rectal Microbicide Development From an Acceptability Trial of a Placebo Gel Applied Prior to Receptive Anal Intercourse.

Authors:  Timothy Frasca; Rebecca Giguere; Mobolaji Ibitoye; Curtis Dolezal; Irma Febo; Ross D Cranston; Kenneth Mayer; Ian McGowan; Alex Carballo-Diéguez
Journal:  Arch Sex Behav       Date:  2016-04-29

10.  Acceptability of potential rectal microbicide delivery systems for HIV prevention: a randomized crossover trial.

Authors:  Heather A Pines; Pamina M Gorbach; Robert E Weiss; Kristen Hess; Ryan Murphy; Terry Saunders; Joelle Brown; Peter A Anton; Ross D Cranston
Journal:  AIDS Behav       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.